3 reports

  • 6.2.1 KEY STRATEGIES - ACQUISITIONS AND MERGERS - 1
  • MAJOR INVESTMENTS IN THE LIQUID BIOPSY MARKET (2010-2017) - 3

Strobeck, Jack Schuler, Oracle Investment Management Inc. ## 2013 Celsee Diagnostics (US) ## Debt Financing Ann Arbor SPARK ## 2012 Biodesix, Inc.

  • Diagnostics
  • Genetic Testing
  • Biocept, Inc.
  • Biodesix Inc.
  • RainDance Technologies, Inc.
  • RAINDANCE TECHNOLOGIES INC, DEALS BY MARKET, 2012 TO YTD 2018
  • RAINDANCE TECHNOLOGIES RAISES US$20 MILLION IN SERIES E FINANCING

Deal Rationale Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases.

  • Diagnostics
  • Medical Biotechnology
  • Medical Equipment
  • United States
  • RainDance Technologies, Inc.
  • RAINDANCE TECHNOLOGIES RAISES US$20 MILLION IN SERIES E FINANCING
  • RAINDANCE TECHNOLOGIES ENTERS INTO CO-DEVELOPMENT AGREEMENT WITH MLL MUNCHNER LEUKAMIE LABOR

Deal Rationale Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases.

  • Diagnostics
  • Healthcare
  • Molecular Diagnostics
  • Pharmaceutical
  • RainDance Technologies, Inc.